Hua Rui, Li Qing, Wong Ian Yat Hin, Ning Hong, Wang Hailin
Department of Ophthalmology, First Hospital of China Medical University, Shenyang, China.
Department of Ophthalmology, University of Hong Kong, Hong Kong, China.
Oncotarget. 2017 Jan 10;8(2):2034-2036. doi: 10.18632/oncotarget.14020.
Diabetes is a common endocrine disorder associated with peripheral microvascular diseases such as proliferative retinal microangiopathy (or diabetic retinopathy), which may lead to blindness. Unfortunately, diabetic microvascular abnormalities in the choroid are underestimated in clinical practice. Recent literature has revealed that the severity of diabetic retinopathy is aggravated by choroidopathy resulting from hyperglycemia. Here, we introduce a case of diabetic retinopathy with choroidal neovascularization membrane but without signs of retinal microvascular proliferation or drusen. We investigated the pathogenesis of choroidal microvascular proliferation secondary to diabetes. We postulate that choroidal neovascularization is an intraocular microvascular complication of diabetes mellitus. Intravitreal anti-vascular endothelial growth factor therapy may be a treatment option for microvascular proliferation in both retina and choroids.
糖尿病是一种常见的内分泌疾病,与外周微血管疾病相关,如增殖性视网膜微血管病变(或糖尿病性视网膜病变),这可能导致失明。不幸的是,脉络膜的糖尿病微血管异常在临床实践中被低估。最近的文献表明,高血糖导致的脉络膜病变会加重糖尿病性视网膜病变的严重程度。在此,我们介绍一例患有脉络膜新生血管膜但无视网膜微血管增殖或玻璃膜疣迹象的糖尿病性视网膜病变病例。我们研究了糖尿病继发脉络膜微血管增殖的发病机制。我们推测脉络膜新生血管形成是糖尿病的一种眼内微血管并发症。玻璃体内抗血管内皮生长因子治疗可能是视网膜和脉络膜微血管增殖的一种治疗选择。